New Synthesis of HIV Drug Dolutegravir Sodium

  • Author: ChemistryViews.org
  • Published: 18 July 2021
  • Copyright: Wiley-VCH GmbH
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: New Synthesis of HIV Drug Dolutegravir Sodium

Dolutegravir is an antiretroviral drug used in the treatment of HIV/AIDS, usually in the form of its sodium salt (pictured). It acts as an integrase strand transfer inhibitor (INSTI), i.e., it interferes with the HIV integrase enzyme and prevents it from inserting viral DNA into the human genome. In existing syntheses of this drug, the pyridone ring is generally constructed first and then undergoes cyclization with (R)-3-amino-1-butanol to form additional rings.


Till Opatz, Johannes Gutenberg University, Mainz, Germany, and colleagues have developed an alternative, practical synthesis of dolutegravir sodium that starts from (R)-3-amino-1-butanol. They developed a four-step process that forms a bicyclic amine fragment from this starting compound via an N-acylation, an N-alkylation, and an intramolecular transacetalization. Then, the pyridone ring was formed using a 1,4-addition with an enol ether and a regioselective cyclization. Finally, the 2,4-difluorobenzylamine group was introduced to give dolutegravir, which was converted to the sodium salt.


The team obtained dolutegravir sodium in an isolated yield of up to 51 % over six linear steps. The synthesis was performed on a gram scale. According to the researchers, the developed synthetic route could be useful in industry. This might help to ensure the supply of this important antiretroviral drug.


 

 

Article Views: 561

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permisson guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH